Life Sciences industry

How the EY Life Sciences team empowers companies to transform.

As life sciences business models evolve amid rising demand for personalized care and transformative technologies such as GenAI and automation, the EY Life Sciences team is at the forefront of change. Our global network of professionals is backed by deep sector knowledge and powerful alliances across tech and other industries.

We collaborate closely with pharma, biotech and medical technology leaders to drive innovation and enhance operational performance. Our teams also deploy data-driven innovation across the value chain, empowering clients to shape the future with confidence as they develop strategies for launch excellence, operational efficiency and sustainable business outcomes that transform patient care.

Key research and reports

Life Sciences industry

How Bristol Myers Squibb overhauled working capital to fund its future

EY-Parthenon team helped BMS establish a cash leadership office as part of an award-winning Treasury transformation. Learn more in this case study.

Discover our curated library of other life sciences insights, from R&D to finance, innovation and more.

Knowledge sharing and news (11)

Skip

west

How can treasurers transform to realize new value in a world of uncertainty?

How can treasurers transform to realize new value in a world of uncertainty?

Beyond integration: Value creation from bolt-on life sciences deals

Beyond integration: Value creation from bolt-on life sciences deals

How an authentic journey brought leadership success

How an authentic journey brought leadership success

How life sciences legal departments can create financial efficiency

How life sciences legal departments can create financial efficiency

How life sciences CIOs can make the most of GenAI investments

How life sciences CIOs can make the most of GenAI investments

Transforming compliance with advanced strategies and technologies

Transforming compliance with advanced strategies and technologies

Why agentic AI is a revolution stuck in an evolution

Why agentic AI is a revolution stuck in an evolution

Enhance supply chain efficiency and autonomous operations with innovative solutions from EY and NVIDIA teams

Enhance supply chain efficiency and autonomous operations with innovative solutions from EY and NVIDIA teams

Transforming supply chain strategy with AI

Transforming supply chain strategy with AI

How to build real-time supply chain cost monitoring with agentic AI

How to build real-time supply chain cost monitoring with agentic AI

Evolving data management: 3 ways to scale AI for the future

Evolving data management: 3 ways to scale AI for the future

east

Featured Webcasts and Podcasts

Watch live or replay webcasts now. Registration may be required.

The team

Linda Hill

EY Global and Americas Consumer and Health Leader

Strategic leader focused on innovation. Collaborative team builder. Champion for audit quality. Client-centric problem solver. Avid reader. Ambitious hiker. Occasional middle school sports coach.

St. Louis, MO, United States

Arda Ural, PhD

EY Americas Life Sciences Leader

Frequent speaker about biopharmaceutical strategy at industry conferences. Married father of two.

New York, NY, United States

Richard Ramko

EY Americas Life Sciences Sector and Biotechnology Leader

Experienced life sciences advisor. Serves on charitable boards.

San Mateo – Silicon Valley, CA, United States

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.